APO RESEARCH · REPORT
Pimozide
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Product & engineering
Understand the product.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Selected research
Industry Research
Pimozide Industry Research Report 2026
Market perspective
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
Read the full market overview
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
Report Scope
This report quantifies the global Pimozide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pimozide Market by Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Pimozide Segment by Type
1Mg
2Mg
4Mg
Pimozide Segment by Application
Hospitals
Drugstores
Others
Pimozide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimozide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pimozide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimozide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pimozide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pimozide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pimozide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1Mg
- 2Mg
- 4Mg
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- Teva
- Par Pharmaceutical
- Johnson & Johnson
- Eumedica
- Pharmascience
- Domina Pharmaceuticals
- Aa Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pimozide Market Size (2021-2032)
- 2.2.2 Global Pimozide Sales (2021-2032)
- 2.2.3 Global Pimozide Market Average Price (2021-2032)
- 2.3 Pimozide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1Mg
- 2.3.3 2Mg
- 2.3.4 4Mg
- 2.4 Pimozide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Drugstores
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pimozide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pimozide Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pimozide Revenue of Manufacturers (2021-2026)
- 3.4 Global Pimozide Average Price by Manufacturers (2021-2026)
- 3.5 Global Pimozide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pimozide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pimozide, Product Type & Application
- 3.8 Global Manufacturers of Pimozide, Established Date
- 3.9 Global Pimozide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pimozide Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Par Pharmaceutical
- 4.2.1 Par Pharmaceutical Company Information
- 4.2.2 Par Pharmaceutical Business Overview
- 4.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Par Pharmaceutical Pimozide Product Portfolio
- 4.2.5 Par Pharmaceutical Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Pimozide Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Eumedica
- 4.4.1 Eumedica Company Information
- 4.4.2 Eumedica Business Overview
- 4.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eumedica Pimozide Product Portfolio
- 4.4.5 Eumedica Recent Developments
- 4.5 Pharmascience
- 4.5.1 Pharmascience Company Information
- 4.5.2 Pharmascience Business Overview
- 4.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pharmascience Pimozide Product Portfolio
- 4.5.5 Pharmascience Recent Developments
- 4.6 Domina Pharmaceuticals
- 4.6.1 Domina Pharmaceuticals Company Information
- 4.6.2 Domina Pharmaceuticals Business Overview
- 4.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
- 4.6.5 Domina Pharmaceuticals Recent Developments
- 4.7 Aa Pharma
- 4.7.1 Aa Pharma Company Information
- 4.7.2 Aa Pharma Business Overview
- 4.7.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Aa Pharma Pimozide Product Portfolio
- 4.7.5 Aa Pharma Recent Developments
5 Global Pimozide Market Scenario by Region
- 5.1 Global Pimozide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pimozide Sales by Region: 2021-2032
- 5.2.1 Global Pimozide Sales by Region: 2021-2026
- 5.2.2 Global Pimozide Sales by Region: 2027-2032
- 5.3 Global Pimozide Revenue by Region: 2021-2032
- 5.3.1 Global Pimozide Revenue by Region: 2021-2026
- 5.3.2 Global Pimozide Revenue by Region: 2027-2032
- 5.4 North America Pimozide Market Facts & Figures by Country
- 5.4.1 North America Pimozide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pimozide Sales by Country (2021-2032)
- 5.4.3 North America Pimozide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pimozide Market Facts & Figures by Country
- 5.5.1 Europe Pimozide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pimozide Sales by Country (2021-2032)
- 5.5.3 Europe Pimozide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pimozide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pimozide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pimozide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pimozide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pimozide Market Facts & Figures by Country
- 5.7.1 South America Pimozide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pimozide Sales by Country (2021-2032)
- 5.7.3 South America Pimozide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pimozide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pimozide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pimozide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pimozide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pimozide Sales by Type (2021-2032)
- 6.1.1 Global Pimozide Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pimozide Sales Market Share by Type (2021-2032)
- 6.2 Global Pimozide Revenue by Type (2021-2032)
- 6.2.1 Global Pimozide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pimozide Revenue Market Share by Type (2021-2032)
- 6.3 Global Pimozide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pimozide Sales by Application (2021-2032)
- 7.1.1 Global Pimozide Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pimozide Sales Market Share by Application (2021-2032)
- 7.2 Global Pimozide Revenue by Application (2021-2032)
- 7.2.1 Global Pimozide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pimozide Revenue Market Share by Application (2021-2032)
- 7.3 Global Pimozide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pimozide Value Chain Analysis
- 8.1.1 Pimozide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pimozide Production Mode & Process
- 8.2 Pimozide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pimozide Distributors
- 8.2.3 Pimozide Customers
9 Global Pimozide Analyzing Market Dynamics
- 9.1 Pimozide Industry Trends
- 9.2 Pimozide Industry Drivers
- 9.3 Pimozide Industry Opportunities and Challenges
- 9.4 Pimozide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst